ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Pengyu Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8878-7191; OpenAlex author ID A5127804416. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.drup.2026.101385 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Danqi Fu · 1 shared paper, 2026 · strength 0.24
- Paper The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2026.101385 ↗
Chunhua She · 1 shared paper, 2026 · strength 0.24
- Paper The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2026.101385 ↗
Jing Hu · 1 shared paper, 2026 · strength 0.24
- Paper The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2026.101385 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.